AUTL Stock Analysis: Buy, Sell, or Hold?

AUTL - Autolus Therapeutics plc American Depositary Share

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$1.57
-0.04 (-2.48%) ▼
5d: +6.8%
30d: +6.8%
90d: +10.56%
BUY
HIGH Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 14, 2026 5d

Get Alerted When AUTL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: AUTL shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: AUTL is currently trading at $1.57, which is considered slightly high relative to its 30-day fair value range of $1.39 to $1.59.

Technical Outlook: Technically, AUTL is in a downtrend. Immediate support is located at $1.39, while resistance sits at $1.75.

Market Sentiment: AUTL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.68 (+452.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $1.39 - $1.59
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 78.9%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 452.7% below Wall St target ($8.68)

Trading Range Analysis

30-Day Trading Range $1.39 - $1.59
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $1.39
Resistance Level $1.75
Current Trend Downtrend
Technical data as of May 8, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.22
Wall Street Target $8.68 (+452.7%)
Revenue Growth (YoY) 83655.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 08, 2026 6:15 PM ET
Data refreshes hourly during market hours. Next update: 7:15 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for AUTL.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$100 69 BUY
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$93 61 BUY
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$30 58 HOLD
BHVN
Biohaven Pharmaceutical …
STRONG BUY
16 analysts
$22 56 HOLD

More Analysis for AUTL

AUTL Technical Chart AUTL Price Prediction AUTL Earnings Date AUTL Investment Advisor AUTL Fair Price Analyzer AUTL Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals